Europe Insulin Delivery Devices Market Growth, Size, Trends, Revenue, Demand and Future Outlook
Europe Insulin Delivery Devices Market Size– By Type, By Application, By Distribution Channel, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
| Published: Feb-2024 | Report ID: HLCA2418 | Pages: 1 - 152 | Formats*: |
| Category : Healthcare | |||
Europe Insulin Delivery Devices Market Introduction and Overview
According to SPER Market Research, the Europe Insulin Delivery Devices Market is estimated to reach USD 3.54 billion by 2033 with CAGR of 3.19%.
The report includes an in-depth analysis of the Europe Insulin Delivery Devices Market, including market size and trends, product mix, applications, and supplier analysis. All individuals with Type 1 and Type 2 diabetes fundamentally require insulin as part of their treatment regimen. The insulin delivery device is administered directly into the subcutaneous fatty tissues using insulin pens, syringes, insulin pumps, and jet injectors. More advanced insulin delivery devices have been developed as a result of the growing demand for minimally invasive administration methods, particularly in underserved areas of the globe.
- April 2022: CamDiab and Ypsomed announced their collaboration to create and market an integrated automated insulin delivery (AID) system, which will enable diabetics in Europe manage their condition more easily
- October 2022: Medtronic unveiled My Insights, a brand-new application designed specifically for users of the MiniMed 770G system. My Insights leverages the power of data science to deliver clients personalized suggestions, trends, and reminders to help them achieve their diabetes management objectives based on their particular data.
Market Opportunities and Challenges
The market for insulin delivery devices has grown as a result of a number of significant factors, including an increase in the number of people with diabetes, an increase in diabetes-related spending, collaboration between the public and private sectors to address diabetes needs, favourable insurance and reimbursement policies, and device insurance. Further contributing to the market's overall growth are variables like different government subsidies and advantageous reimbursement environments in particular nations, as well as the start of conferences, seminars, and congresses to raise awareness of insulin delivery devices. Profitable opportunities for the market are anticipated as a result of the sharp growth in R&D activity and healthcare spending.
However, the market for insulin delivery devices is primarily being challenged by low adoption of insulin pumps, limited access to healthcare, and the availability of high-cost management in Europe. A patient may experience injury from an inappropriate insulin dosage. Furthermore, children under the age of eighteen are not allowed to use the devices. A significant obstacle facing the market is the quantity of insulin delivery devices that use short-acting insulin. The primary challenges that are thought to be impeding the market's growth are the inadequate reimbursement structure and the different problems associated with the reuse of pen needles and infusion sets. Additionally, the market's growth rate is hampered by the high costs of insulin delivery devices, the general lack of understanding of these devices' benefits, and the availability of substitute products.
Market Competitive Landscape
Insulin delivery apparatuses the competitive landscape of the market offers information by rival. Overview of the company, financials, revenue, market potential, R&D investment, new market initiatives, presence in Europe, production facilities and capacities, company strengths and weaknesses are among the details included. Some of major players are Medtronic, F Hoffmann-La Roche Ltd., Insulet Corporation, Tandem Diabetes Care Inc., Sanofi, Johnson & Johnson Private Limited ., Abbott, Terumo Corporation, AstraZeneca, B. Braun Melsungen AG, Julphar, Eli Lily and Company, Biocon, WOCKHARDT and various others.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2033 |
| Base year considered | 2022 |
| Forecast period | 2023-2033 |
| Segments covered | By Type, By Application, By Distribution Channel, By End Use |
| Regions covered | Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe |
| Companies Covered | Medtronic, F Hoffmann-La Roche Ltd., Insulet Corporation, Tandem Diabetes Care Inc., Sanofi, Johnson & Johnson Private Limited ., Abbott, Terumo Corporation, AstraZeneca, B. Braun Melsungen AG, Julphar, Eli Lily and Company, Biocon, WOCKHARDT and various others. |
COVID-19 Impact on Europe Insulin Delivery Devices Market
The COVID-19 pandemic had a major impact on the insulin delivery device market. COVID-19 affects patients with type 1 diabetes more frequently. When exposed to COVID-19, persons with diabetes rapidly decline due to their already weakened immune systems. Diabetes patients may be more vulnerable to serious issues than healthy people. Insulin delivery device makers have taken care to give these devices to diabetic patients during COVID-19, with help from local governments. Diabetes patients should exercise caution and check their blood sugar levels more frequently, according to medical professionals worldwide. A rise in medicine intake has led to an increase in the use of insulin delivery devices.
Key Target Audience:
- Manufacturers and Suppliers
- Healthcare Providers and Facilities
- Pharmaceutical Companies
- Patients and Caregivers
- Health Insurance Companies
- Regulatory Authorities
- Research and Development Organizations
- Academic Institutions
- Patient Advocacy Groups
- Investors and Financial Institutions
- Government Health Departments
Our in-depth analysis of the Europe Insulin Delivery Devices Market includes the following segments:
| By Type: |
|
| By Application: |
|
| By Distribution Channel: |
|
| By End Use: |
|
Key Topics Covered in the Report:
- Europe Insulin Delivery Devices Market Size (FY’2023-FY’2033)
- Overview of Europe Insulin Delivery Devices Market
- Segmentation of Europe Insulin Delivery Devices Market By Type (Insulin Syringes, Insulin Jet Injectors, Pen Needles, Insulin Pumps)
- Segmentation of Europe Insulin Delivery Devices Market By Application (Type I Diabetes, Type II Diabetes)
- Segmentation of Europe Insulin Delivery Devices Market By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics)
- Segmentation of Europe Insulin Delivery Devices Market By End Use (Hospitals, Clinics, Homecare, Specialty Centres)
- Statistical Snap of Europe Insulin Delivery Devices Market
- Expansion Analysis of Europe Insulin Delivery Devices Market
- Problems and Obstacles in Europe Insulin Delivery Devices Market
- Competitive Landscape in the Europe Insulin Delivery Devices Market
- Impact of COVID-19 and Demonetization on Europe Insulin Delivery Devices Market
- Details on Current Investment in Europe Insulin Delivery Devices Market
- Competitive Analysis of Europe Insulin Delivery Devices Market
- Prominent Players in the Europe Insulin Delivery Devices Market
- SWOT Analysis of Europe Insulin Delivery Devices Market
1.Introduction
1.1.Scope of the report1.2.Market segment analysis
2.Research Methodology
2.1.Research data source2.1.1.Secondary Data2.1.2.Primary Data2.1.3.SPER’s internal database2.1.4.Premium insight from KOL’s2.2.Market size estimation2.2.1.Top-down and Bottom-up approach2.3.Data triangulation
3.Executive Summary
4.Market Dynamics
4.1.Driver, Restraint, Opportunity and Challenges analysis4.1.1.Drivers4.1.2.Restraints4.1.3.Opportunities4.1.4.Challenges4.2.COVID-19 Impacts of the Europe Insulin Delivery Devices Market
5.Market variable and outlook
5.1.SWOT Analysis5.1.1.Strengths5.1.2.Weaknesses5.1.3.Opportunities5.1.4.Threats5.2.PESTEL Analysis5.2.1.Political Landscape5.2.2.Economic Landscape5.2.3.Social Landscape5.2.4.Technological Landscape5.2.5.Environmental Landscape5.2.6.Legal Landscape5.3.PORTER’s Five Forces5.3.1.Bargaining power of suppliers5.3.2.Bargaining power of buyers5.3.3.Threat of Substitute5.3.4.Threat of new entrant5.3.5.Competitive rivalry5.4.Heat Map Analysis
6.Competitive Landscape
6.1. Europe Insulin Delivery Devices Market Manufacturing Base Distribution, Sales Area, Application Type6.2.Mergers & Acquisitions, Partnerships, Type Launch, and Collaboration in Europe Insulin Delivery Devices Market
7. Europe Insulin Delivery Devices Market, By Type, 2019-2033 (USD Million)
7.1. Europe Insulin Delivery Devices Market Value Share and Forecast, By Type, 2023-20337.2.Insulin Jet Injectors7.3.Insulin Pumps7.4.Insulin Syringes7.5.Pen Needles
8.Europe Insulin Delivery Devices Market, By Application, 2019-2033 (USD Million)
8.1. Europe Insulin Delivery Devices Market Value Share and Forecast, By Application, 2023-20338.2.Type I Diabetes8.3.Type II Diabetes
9.Europe Insulin Delivery Devices Market, By Distribution Channel, 2019-2033 (USD Million)
9.1. Europe Insulin Delivery Devices Market Value Share and Forecast, By Distribution Channel, 2023-20339.2.Diabetes Clinics9.3.Hospital Pharmacy9.4.Online Sales9.5.Retail Pharmacy
10.Europe Insulin Delivery Devices Market, By End Use, 2019-2033 (USD Million)
10.1. Europe Insulin Delivery Devices Market Value Share and Forecast, By End Use, 2023-203310.2.Clinics10.3.Homecare10.4.Hospitals10.5.Specialty Centres
11. Europe Insulin Delivery Devices Market Forecast, 2019-2033 (USD Million)
11.1. Europe Insulin Delivery Devices Market Size and Market Share
12.Europe Insulin Delivery Devices Market, By Type, 2019-2033 (USD Million)
12.1. Europe Insulin Delivery Devices Market Size and Market Share By Type (2019-2026)12.2. Europe Insulin Delivery Devices Market Size and Market Share By Type (2027-2033)
13.Europe Insulin Delivery Devices Market, By Application, 2019-2033 (USD Million)
13.1. Europe Insulin Delivery Devices Market Size and Market Share By Application (2019-2026)13.2. Europe Insulin Delivery Devices Market Size and Market Share By Application (2027-2033)
14. Europe Insulin Delivery Devices Market, By Distribution Channel, 2019-2033 (USD Million)
14.1. Europe Insulin Delivery Devices Market Size and Market Share By Distribution Channel (2019-2026)14.2. Europe Insulin Delivery Devices Market Size and Market Share By Distribution Channel (2027-2033)
15.Europe Insulin Delivery Devices Market, By End Use, 2019-2033 (USD Million)
15.1. Europe Insulin Delivery Devices Market Size and Market Share By End Use (2019-2026)15.2. Europe Insulin Delivery Devices Market Size and Market Share By End Use (2027-2033)
16. Europe Insulin Delivery Devices Market, By Region, 2019-2033 (USD Million)
16.1. Europe Insulin Delivery Devices Market Size and Market Share By Region (2019-2026)16.2. Europe Insulin Delivery Devices Market Size and Market Share By Region (2027-2033)16.2.1.Belgium16.2.2.France16.2.3.Germany16.2.4.Italy16.2.5.Netherland16.2.6.Russia16.2.7.Spain16.2.8.Switzerland16.2.9.Turkey16.2.10.U.K.16.2.11.Rest of Europe
17.Company Profile
17.1.Abbott17.1.1.Company details17.1.2.Financial outlook17.1.3.Type summary17.1.4.Recent developments17.2.Biocon17.2.1.Company details17.2.2.Financial outlook17.2.3.Type summary17.2.4.Recent developments17.3.Eli Lily and Company17.3.1.Company details17.3.2.Financial outlook17.3.3.Type summary17.3.4.Recent developments17.4.Johnson & Johnson Private Limited17.4.1.Company details17.4.2.Financial outlook17.4.3.Type summary17.4.4.Recent developments17.5.Medtronic17.5.1.Company details17.5.2.Financial outlook17.5.3.Type summary17.5.4.Recent developments17.6.Tandem Diabetes Care Inc.17.6.1.Company details17.6.2.Financial outlook17.6.3.Type summary17.6.4.Recent developments17.7.Others
15List of Abbreviations
16Reference Links
17Conclusion
18Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
The Europe is anticipated to have the highest market share in the Europe Insulin Delivery Devices Market.
"The key players in the market include Companies Covered Medtronic, F Hoffmann-La Roche Ltd., Insulet Corporation, Tandem Diabetes Care Inc., Sanofi, Johnson & Johnson Private Limited ., Abbott, Terumo Corporation, AstraZeneca, B. Braun Melsungen AG, Julphar, Eli Lily and Company, Biocon, WOCKHARDT and various others."
A patient may experience injury from an inappropriate insulin dosage. Furthermore, children under the age of eighteen are not allowed to use the devices.
Europe Insulin Delivery Devices Market is projected to reach USD 3.54 billion by 2033, growing at a CAGR of 3.19% during the forecast period.
Europe Insulin Delivery Devices Market size from 2022. The Market is expected to reach USD 3.54 billion by 2033, at a CAGR of 3.19% during the forecast period.
Europe Insulin Delivery Devices Market CAGR of 3.19% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Europe Insulin Delivery Devices Market size is 3.54 billion from 2023 to 2033.
Europe Insulin Delivery Devices Market Segment is covered By Type, By Application, By Distribution Channel, By End Use.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
